Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor

BACKGROUND: Safety and significant improvement in overall glycated hemoglobin (A1C) and percentage of time spent in (TIR), below (TBR), and above (TAR) glucose range were demonstrated in the pivotal trial of adolescents and adults using the MiniMed™ advanced hybrid closed-loop (AHCL) system with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordero, Toni L., Dai, Zheng, Arrieta, Arcelia, Niu, Fang, Vella, Melissa, Shin, John, Rhinehart, Andrew S., McVean, Jennifer, Lee, Scott W., Slover, Robert H., Forlenza, Gregory P., Shulman, Dorothy I., Pop-Busui, Rodica, Thrasher, James R., Kipnes, Mark S., Christiansen, Mark P., Buckingham, Bruce A., Pihoker, Catherine, Sherr, Jennifer L., Kaiserman, Kevin B., Vigersky, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460682/
https://www.ncbi.nlm.nih.gov/pubmed/37252734
http://dx.doi.org/10.1089/dia.2023.0123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460682/
https://www.ncbi.nlm.nih.gov/pubmed/37252734
http://dx.doi.org/10.1089/dia.2023.0123

Ejemplares similares